These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 31985860)

  • 1. The optimal timing of immunotherapy may improve pregnancy outcome in women with unexplained recurrent pregnancy loss: A perspective follow-up study in northeastern China.
    Hou Y; Li J; Liu Q; Zhang L; Chen B; Li Y; Bian Y; Huang L; Qiao C
    Am J Reprod Immunol; 2020 Apr; 83(4):e13225. PubMed ID: 31985860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effects of LIT and MLR-Bf on Immune Biomarkers and Pregnancy Outcomes in Women With Previous Early Recurrent Miscarriage: A Retrospective Study.
    Meng L; Tan J; Du T; Lin X; Zhang S; Nie X; Xie H; Lin J; Zhang J; Hui C
    Front Immunol; 2021; 12():642120. PubMed ID: 34017330
    [No Abstract]   [Full Text] [Related]  

  • 3. Allogenic Lymphocyte Immunotherapy for Unexplained Recurrent Spontaneous Abortion: A Meta-Analysis.
    Liu Z; Xu H; Kang X; Wang T; He L; Zhao A
    Am J Reprod Immunol; 2016 Dec; 76(6):443-453. PubMed ID: 27105633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mixed lymphocyte reaction blocking factors (MLR-Bf) as potential biomarker for indication and efficacy of paternal lymphocyte immunization in recurrent spontaneous abortion.
    Khonina NA; Broitman EV; Shevela EY; Pasman NM; Chernykh ER
    Arch Gynecol Obstet; 2013 Oct; 288(4):933-7. PubMed ID: 23558562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blocking antibodies in blood from patients with recurrent spontaneous abortion in relation to pregnancy outcome and intravenous immunoglobulin treatment.
    Jablonowska B; Palfi M; Ernerudh J; Kjellberg S; Selbing A
    Am J Reprod Immunol; 2001 Apr; 45(4):226-31. PubMed ID: 11327549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of CD200 expression in paternal lymphocytes with female Th1/Th2 balance and pregnancy establishment at immunotherapy of recurrent spontaneous abortion.
    Arefieva A; Nikolaeva M; Stepanova E; Krechetova L; Golubeva E; Tetruashvili N; Sukhikh G
    Am J Reprod Immunol; 2021 Mar; 85(3):e13355. PubMed ID: 33015886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does immunotherapy for treatment of reproductive failure enhance live births?
    Coulam CB; Acacio B
    Am J Reprod Immunol; 2012 Apr; 67(4):296-304. PubMed ID: 22340745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of recurrent spontaneous abortion by immunization with paternal lymphocytes: results of a controlled trial.
    Gatenby PA; Cameron K; Simes RJ; Adelstein S; Bennett MJ; Jansen RP; Shearman RP; Stewart GJ; Whittle M; Doran TJ
    Am J Reprod Immunol; 1993 Mar; 29(2):88-94. PubMed ID: 8329110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous immunoglobulin for treatment of recurrent pregnancy loss.
    Coulam CB; Krysa L; Stern JJ; Bustillo M
    Am J Reprod Immunol; 1995 Dec; 34(6):333-7. PubMed ID: 8607936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of lymphocyte immunotherapy in the treatment of recurrent pregnancy loss from alloimmunity: A systematic review and meta-analysis.
    Francisco PD; Tan-Lim CSC; Agcaoili-De Jesus MSL
    Am J Reprod Immunol; 2022 Oct; 88(4):e13605. PubMed ID: 35894648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous immunoglobulin for recurrent unexplained pregnancy loss: a case report.
    Barnsfather K; Pietrantoni M
    J Reprod Med; 2007 Aug; 52(8):737-40. PubMed ID: 17879838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of intravenous immunoglobulin treatment on maternal immunity in women with unexplained recurrent miscarriage.
    Maruyama T; Makino T; Iwasaki K; Sugi T; Saito S; Umeuchi M; Ozawa N; Matsubayashi H; Nozawa S
    Am J Reprod Immunol; 1994 Jan; 31(1):7-18. PubMed ID: 8166949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of unexplained recurrent spontaneous abortion using intravenous immunoglobulin: a prospective, randomized, double-blinded, placebo-controlled trial.
    Stephenson MD; Dreher K; Houlihan E; Wu V
    Am J Reprod Immunol; 1998 Feb; 39(2):82-8. PubMed ID: 9506206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy with intravenous immunoglobulin for treatment of recurrent pregnancy loss: American experience.
    Coulam CB
    Am J Reprod Immunol; 1994 Dec; 32(4):286-9. PubMed ID: 7718095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous Immunoglobulin Suppresses Abortion Relates to an Increase in the CD44bright NK Subset in Recurrent Pregnancy Loss Model Mice.
    Tanaka J; Kitashoji A; Fukunaga Y; Kashihara J; Nakano A; Kamizono A
    Biol Reprod; 2016 Aug; 95(2):37. PubMed ID: 27335067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical effect of lymphocyte immunotherapy on patients with unexplained recurrent spontaneous abortion.
    Liu S; Gu X; Weng R
    Immun Inflamm Dis; 2021 Dec; 9(4):1272-1278. PubMed ID: 34102013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphocyte immunotherapy in recurrent miscarriage and recurrent implantation failure.
    Cavalcante MB; Sarno M; Barini R
    Am J Reprod Immunol; 2021 Apr; 85(4):e13408. PubMed ID: 33638199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy with intravenous immunoglobulin for prevention of recurrent pregnancy loss: European experience.
    Mueller-Eckhardt G
    Am J Reprod Immunol; 1994 Dec; 32(4):281-5. PubMed ID: 7718094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfusion-related risks of intradermal allogeneic lymphocyte immunotherapy: single cases in a large cohort and review of the literature.
    Kling C; Steinmann J; Flesch B; Westphal E; Kabelitz D
    Am J Reprod Immunol; 2006 Sep; 56(3):157-71. PubMed ID: 16911711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous immunoglobulin (IVIG): modes of action in the clinical management of recurrent pregnancy loss (RPL) and selected autoimmune disorders.
    Omwandho CO; Gruessner SE; Roberts TK; Tinneberg HR
    Clin Chem Lab Med; 2004 Apr; 42(4):359-70. PubMed ID: 15147144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.